Capital World Investors’s Editas Medicine EDIT Stock Holding History

Capital World Investors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,100,000	Closed	-$9.76M	–	524
2022 Q4	$9.76M	Hold	1,100,000	–	–	﹤0.01%	486
2022 Q3	$13.5M	Hold	1,100,000	–	–	﹤0.01%	481
2022 Q2	$13M	Hold	1,100,000	–	–	﹤0.01%	479
2022 Q1	$20.9M	Hold	1,100,000	–	–	﹤0.01%	492
2021 Q4	$29.2M	Sell	1,100,000 -200,000	-15%	-$6.88M	﹤0.01%	503
2021 Q3	$53.4M	Hold	1,300,000	–	–	0.01%	437
2021 Q2	$73.6M	Hold	1,300,000	–	–	0.01%	409
2021 Q1	$54.6M	Sell	1,300,000 -100,000	-7%	-$5.7M	0.01%	427
2020 Q4	$98.2M	Sell	1,400,000 -360,000	-20%	-$14.8M	0.02%	346
2020 Q3	$49.4M	Hold	1,760,000	–	–	0.01%	395
2020 Q2	$52.1M	Hold	1,760,000	–	–	0.01%	362
2020 Q1	$34.9M	Hold	1,760,000	–	–	0.01%	356
2019 Q4	$52.1M	Hold	1,760,000	–	–	0.01%	350
2019 Q3	$40M	Hold	1,760,000	–	–	0.01%	355
2019 Q2	$43.5M	Sell	1,760,000 -170,000	-9%	-$4.06M	0.01%	358
2019 Q1	$47.2M	Hold	1,930,000	–	–	0.01%	356
2018 Q4	$43.9M	Sell	1,930,000 -102,000	-5%	-$2.78M	0.01%	355
2018 Q3	$64.7M	Sell	2,032,000 -152,000	-7%	-$4.91M	0.02%	355
2018 Q2	$78.3M	Hold	2,184,000	–	–	0.02%	323
2018 Q1	$72.4M	Buy	2,184,000 +414,000	+23%	+$14.8M	0.02%	333
2017 Q4	$54.4M	Hold	1,770,000	–	–	0.01%	347
2017 Q3	$42.5M	Hold	1,770,000	–	–	0.01%	366
2017 Q2	$29.7M	Hold	1,770,000	–	–	0.01%	384
2017 Q1	$39.5M	Buy	1,770,000 +1,475,000	+500%	+$30.6M	0.01%	369
2016 Q4	$4.79M	Hold	295,000	–	–	﹤0.01%	471
2016 Q3	$3.98M	Hold	295,000	–	–	﹤0.01%	474
2016 Q2	$7.2M	Hold	295,000	–	–	﹤0.01%	462
2016 Q1	$10.2M	Buy	+295,000	New	+$7.75M	﹤0.01%	444

Other funds holding EDIT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Capital World Investors's EDIT Position: Q1 2023 in Review

Capital World Investors sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 1,100,000 shares — an estimated $9.76M sold.

Capital World Investors first reported a position in EDIT in Q1 2016 and held it in 28 quarters. The position peaked at $98.2M in Q4 2020. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

Capital World Investors reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
Capital World Investors sold 1,100,000 Editas Medicine shares in Q1 2023, an estimated $9.76M.
Capital World Investors first reported a position in Editas Medicine in Q1 2016 and held it in 28 quarters.
Capital World Investors's Editas Medicine position peaked at $98.2M in Q4 2020.
234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on Capital World Investors's 13F filing for Q1 2023, filed 15 May 2023.